• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇在治疗非酒精性脂肪肝病的小鼠模型中调节自噬和 NF-κB 活性。

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University, Henan Province, China.

Department of Endocrinology, The First Affiliated Hospital of Xinxiang Medical University, Henan Province, China.

出版信息

Food Chem Toxicol. 2014 Jan;63:166-73. doi: 10.1016/j.fct.2013.08.036. Epub 2013 Aug 24.

DOI:10.1016/j.fct.2013.08.036
PMID:23978414
Abstract

In this study, we aimed to investigate the therapeutic effects and involved mechanisms of resveratrol on an established non-alcoholic fatty liver disease (NAFLD) murine model. Wild-type and autophagic mediator ULK1 heterozygous knockout mice were induced to have NAFLD by high-fat diet for 8weeks. After that, resveratrol treatment was applied with the high-fat diet feeding for another 4weeks. Typical features of NAFLD, including histological changes, fibrosis, insulin resistance, oxidative status, and inflammation were characterized. After-treatment with resveratrol showed ameliorative effects on all measured features of NAFLD, from histology, insulin resistance, glucose tolerance to oxidative stress and inflammation. resveratrol treatment also reduced the activity of nuclear factor-κB (NF-κB) through the restoration of its inhibitor IκBα. Partial inhibition of ULK1 expression impaired the ameliorative effects of resveratrol on hepatic histology, fibrosis, oxidative status, inflammation, and NF-κB activity. In conclusion, resveratrol improved NAFLD-caused hepatic injury partially through regulating autophagic and IκBα-NF-κB pathways.

摘要

在这项研究中,我们旨在研究白藜芦醇对已建立的非酒精性脂肪性肝病(NAFLD)小鼠模型的治疗作用和相关机制。通过高脂肪饮食诱导野生型和自噬介质 ULK1 杂合子敲除小鼠 8 周,使其发生 NAFLD。之后,在高脂肪饮食喂养的同时给予白藜芦醇治疗 4 周。对 NAFLD 的典型特征,包括组织学变化、纤维化、胰岛素抵抗、氧化状态和炎症进行了特征描述。白藜芦醇治疗对 NAFLD 的所有测量特征均显示出改善作用,从组织学、胰岛素抵抗、葡萄糖耐量到氧化应激和炎症。白藜芦醇治疗还通过恢复其抑制剂 IκBα 来降低核因子-κB(NF-κB)的活性。ULK1 表达的部分抑制削弱了白藜芦醇对肝组织学、纤维化、氧化状态、炎症和 NF-κB 活性的改善作用。总之,白藜芦醇通过调节自噬和 IκBα-NF-κB 途径部分改善了 NAFLD 引起的肝损伤。

相似文献

1
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.白藜芦醇在治疗非酒精性脂肪肝病的小鼠模型中调节自噬和 NF-κB 活性。
Food Chem Toxicol. 2014 Jan;63:166-73. doi: 10.1016/j.fct.2013.08.036. Epub 2013 Aug 24.
2
Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.白藜芦醇通过减少脂肪生成和炎症来减轻高脂喂养小鼠的肝脂肪变性。
Nutrition. 2014 Jul-Aug;30(7-8):915-9. doi: 10.1016/j.nut.2013.11.016. Epub 2013 Dec 4.
3
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
4
Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.白藜芦醇可预防调节性 T 细胞生成受抑制、氧化应激和炎症,可预防易发生或抵抗高脂肪饮食诱导肥胖的小鼠发生上述情况。
Nutr Res. 2013 Nov;33(11):971-81. doi: 10.1016/j.nutres.2013.07.016. Epub 2013 Aug 27.
5
Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.白藜芦醇通过调节自噬改善蛋氨酸/胆碱缺乏饮食诱导的脂肪性肝炎中的肝脂肪变性和炎症。
Lipids Health Dis. 2015 Oct 24;14:134. doi: 10.1186/s12944-015-0139-6.
6
Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.过氧化物酶体增殖物激活受体-α激动剂 Wy 14,643 可改善非酒精性脂肪性肝炎糖尿病小鼠的代谢指标、脂肪变性和气球样变。
J Gastroenterol Hepatol. 2012 Feb;27(2):341-50. doi: 10.1111/j.1440-1746.2011.06939.x.
7
Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.吡格列酮通过下调核因子-κB 和环氧化酶-2 在大鼠肝脏中的表达改善非酒精性脂肪性肝炎。
Chin Med J (Engl). 2012 Jul;125(13):2316-21.
8
Resveratrol induces nuclear factor-κB activity in human cardiac cells.白藜芦醇诱导人心细胞核因子-κB 活性。
Int J Cardiol. 2013 Sep 10;167(6):2507-16. doi: 10.1016/j.ijcard.2012.06.006. Epub 2012 Jun 27.
9
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.乙酰左旋肉碱和硫辛酸可改善非酒精性脂肪性肝病小鼠模型的线粒体异常和血清肝酶水平。
Nutr Res. 2013 Nov;33(11):932-41. doi: 10.1016/j.nutres.2013.08.001. Epub 2013 Sep 18.
10
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A.水杨酸盐和脂联素通过抑制肝源性激素胎球蛋白-A 改善肝脂肪变性。
Biochem Pharmacol. 2013 Oct 1;86(7):960-9. doi: 10.1016/j.bcp.2013.07.034. Epub 2013 Aug 13.

引用本文的文献

1
Targeting cAMP signaling and phosphodiesterase 4 for liver disease treatment.以环磷酸腺苷(cAMP)信号传导和磷酸二酯酶4为靶点治疗肝脏疾病。
Med Chem Res. 2024 Aug;33(8):1339-1353. doi: 10.1007/s00044-024-03267-3. Epub 2024 Jun 26.
2
The Beneficial Effects of Resveratrol on Hepatocellular Carcinoma and Nonalcoholic Fatty Liver Disease: Modulation of Apoptosis, Autophagy, Inflammation, and Oxidative Stress.白藜芦醇对肝细胞癌和非酒精性脂肪性肝病的有益作用:对细胞凋亡、自噬、炎症和氧化应激的调节
Food Sci Nutr. 2025 Jul 24;13(7):e70555. doi: 10.1002/fsn3.70555. eCollection 2025 Jul.
3
Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review.
代谢功能障碍相关脂肪性肝病引起的抗氧化系统变化:综述
Arch Toxicol. 2025 Jan;99(1):1-22. doi: 10.1007/s00204-024-03889-x. Epub 2024 Oct 23.
4
Autophagy alterations in obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease: the evidence from human studies.肥胖、2 型糖尿病和代谢功能障碍相关脂肪性肝病中自噬的改变:来自人体研究的证据。
Intern Emerg Med. 2024 Aug;19(5):1473-1491. doi: 10.1007/s11739-024-03700-w. Epub 2024 Jul 6.
5
Differentially disrupted spinal cord and muscle energy metabolism in spinal and bulbar muscular atrophy.脊髓和延髓肌萎缩症中脊髓和肌肉能量代谢的差异失调。
JCI Insight. 2024 Mar 5;9(7):e178048. doi: 10.1172/jci.insight.178048.
6
Functional Food Chemical Ingredient Strategies for Non-alcoholic Fatty Liver Disease (NAFLD) and Hepatic Fibrosis: Chemical Properties, Health Benefits, Action, and Application.非酒精性脂肪性肝病(NAFLD)和肝纤维化的功能性食品化学成分策略:化学性质、健康益处、作用及应用
Curr Nutr Rep. 2024 Mar;13(1):1-14. doi: 10.1007/s13668-023-00514-8. Epub 2024 Jan 3.
7
Resveratrol protects against Schistosoma mansoni-induced liver fibrosis by targeting the Sirt-1/NF-κB axis.白藜芦醇通过靶向 Sirt-1/NF-κB 轴防治曼氏血吸虫诱导的肝纤维化。
Inflammopharmacology. 2024 Feb;32(1):763-775. doi: 10.1007/s10787-023-01382-y. Epub 2023 Dec 2.
8
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.白藜芦醇治疗非酒精性脂肪性肝病的综合证据构建:临床前和临床荟萃分析
Front Pharmacol. 2023 Sep 12;14:1230783. doi: 10.3389/fphar.2023.1230783. eCollection 2023.
9
Dysfunction of autophagy in high-fat diet-induced non-alcoholic fatty liver disease.高脂饮食诱导的非酒精性脂肪性肝病中自噬功能障碍
Autophagy. 2024 Feb;20(2):221-241. doi: 10.1080/15548627.2023.2254191. Epub 2023 Sep 12.
10
A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway.二甲双胍和白藜芦醇的新组合通过 cAMP/AMPK/SIRT1 信号通路激活自噬来减轻肝脂肪变性。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3135-3148. doi: 10.1007/s00210-023-02520-7. Epub 2023 May 20.